- Trump Budget: $800 Billion in Medicaid Cuts
- Trump’s Health Secretary Isn’t a Fan of the ‘Gold Standard’ Substance-Use Treatment — Bad News for the Opioid Crisis
- How Effective Is Medication-Assisted Treatment for Addiction? Here’s the Science
- 3 Barriers to Medication-Assisted Treatment for Drug Court Participants and How They Can Be Overcome
- Opioid Crisis Becomes Central Issue in Debate Over Medicaid
- U.S. News Article Series on the Opioid Epidemic
- New Approaches Help Babies Get Through Opioid Withdrawal
- Research Results: Treatments Compared for Neonatal Abstinence Syndrome
- US Hepatitis C Cases Soar on Spike in Heroin Use
- High Rates of Hepatitis C in Pregnancy Mirror Opioid Epidemic: CDC
- From Pill to Needle: Prescription Opioid Epidemic May Be Increasing Drug Injection
- Seven Countries That Beat an Overdose Crisis
Links to National News of Interest
- Opinion – Why taking drugs to treat addiction doesn’t mean you’re ‘still addicted’ – 5/18/17
- It’s often family to the rescue during opioid ODs – 5/17/17
- William White Blog: Troubling New Directions in U.S. Drug Policy – 5/16/17
- Four things Americans should know about Dr. Scott Gottlieb, the new head of the FDA – 5/10/17
Links to State News of Interest
“Donald Trump’s budget that is expected to be unveiled on Tuesday will include $800 billion in cuts to Medicaid — a move that underscores the President’s resolve to significantly downsize the federal program even as Republican lawmakers are clashing over the issue in Congress.
The $800 billion reduction, confirmed to CNN Sunday evening by a senior administration official, assumes that the GOP health care bill that the House passed earlier this month would become law, that official said.”
Source: CNN.com – May 22, 2017
Trump’s Health Secretary Isn’t a Fan of the ‘Gold Standard’ Substance-Use Treatment — Bad News for the Opioid Crisis
“US Health and Human Services Secretary Tom Price was visiting West Virginia on Tuesday for a “listening tour” to brainstorm solutions to the current opioid crisis when a reporter asked Price his thoughts on various drug treatment options, according to a report from the Charleston Gazette-Mail.
While Price echoed the Obama administration by calling substance-use disorder a “disease” and the crisis a “public health issue” and not a “criminal justice issue,” Price went against the prevailing wisdom on treatment options.
Price touted the success of faith-based treatment programs, and was decidedly non-supportive of medication-assisted treatment (MAT).”
Source: Businessinsider.com – May 10, 2017
See related article: Communities Key to Fighting Opioid Crisis, HHS Secretary Says – May 12, 2017 available at: http://www.npr.org/sections/health-shots/2017/05/12/527936103/communities-key-to-fighting-opioid-crisis-hhs-secretary-says
Secretary of Health and Human Services Tom Price sparked a firestorm last week with his comments about medication-assisted treatment, saying that “if we’re just substituting one opioid for another, we’re not moving the dial much” in the nation’s opioid epidemic. Notably, the former surgeon general, Dr. Vivek Murthy, took him to task on Twitter for, as he put it, moving away from evidence-based treatment protocols.
A spokesman for HHS later said that Price supports expanding access to various treatment and recovery services, including medication-assisted treatment, and was only arguing that the treatment that’s right for one person isn’t necessarily right for another.
But how much do we know about the effectiveness of medication-assisted treatment, or MAT, and what do we not know? Here’s STAT’s guide to the science.”
Source: StatNews.com May 15, 2017
3 Barriers to Medication-Assisted Treatment for Drug Court Participants and How They Can Be Overcome
“Efforts have been made to address the limited use of MAT in drug courts. In 2015, the Bureau of Justice Assistance (BJA) began requiring drug courts receiving federal funding to attest in writing that they would not deny eligible candidates access to the program because of their use of an FDA-approved medication for addiction treatment, nor would participants be required to taper off such medications as a condition of graduating from the program. In 2016, the National Drug Court Institute endorsed MAT as a best practice for treatment of opioid use disorder.
Still, adoption has been slow. Below are three well-known barriers to broader availability of MAT for drug court participants, and ways they can be overcome.”
- Barrier #1: Access to MAT for Drug Court Participants
- Barrier #2: Concerns About Diversion
- Barrier #3: Negative Attitudes and Strict Rules
Source: ireta.org – May 9, 2017
Categories: Addiction, Drug Courts & Criminal Justice, Medication-Assisted Treatment (MAT), News Updates, Opioid Abuse/Addiction, Opioids
Tags: Buprenorphine, Criminal Justice, Drug Courts, Methadone Treatment
“The national opioid crisis is becoming a political hurdle for Senate Republicans negotiating an -ObamaCare repeal-and-replace bill that could end the healthcare law’s expansion of Medicaid.
Legislation approved by the House would cut off Medicaid expansion in 2020, ending payouts to states and reducing federal funding to the program by about $880 billion, according to the nonpartisan Congressional Budget Office.
Nearly 30 percent of people receiving health coverage through Medicaid expansion have a mental health or substance use disorder or both, according to the National Council for Behavioral Health.
In states like West Virginia, Ohio and Alaska, Medicaid pays for between 34 to 50 percent of one form of medication-assisted treatment for substance use disorders.”
Source: TheHill.com – May 11, 2017
Part I: A Personal Look at a National Problem
Part II: From Punishing Users to Treating a Disease
Part III: Can Federal and Community Support Solve the Opioid Problem?
Source: USNews.com – May 18, 2017
“Letting mothers and babies room together in the hospital and using methadone or buprenorphine instead of morphine led to shorter stays and other benefits for newborns with neonatal abstinence syndrome (NAS), researchers reported here.
Several studies presented at the Pediatric Academic Societies meeting looked at new approaches for assessing and managing infants who experience drug withdrawal after birth, a growing public health problem related to the ongoing opioid epidemic in the U.S.
“We’re rethinking the field and how we approach these babies. Obviously NAS is a huge burden, but we’re trying to think of ways we can improve care for this vulnerable population,” Derek Williams from Vanderbilt University Medical Center, who moderated one of the sessions, told MedPageToday.”
Read more at: https://www.medpagetoday.com/meetingcoverage/pas/65259
Source: MedPageToday.com – May 12, 2017
Categories: Addiction, Buprenorphine, Medication-Assisted Treatment (MAT), Methadone, News Updates, Opioid Abuse/Addiction, Opioids
Tags: Buprenorphine, Methadone Treatment, Neonatal Abstinence Syndrome
“Sublingual buprenorphine is associated with shorter duration of treatment than oral morphine for infants with neonatal abstinence syndrome, according to a study published online May 4 in the New England Journal of Medicine. The research was published to coincide with the annual meeting of the Pediatric Academic Societies, held from May 6 to 9 in San Francisco.
The researchers found that, compared with morphine, buprenorphine correlated with significantly shorter median duration of treatment (15 versus 28 days) and median length of hospital stay (21 versus 33 days) (both P < 0.001). Adjunctive phenobarbital was administered to 15 and 23 percent of infants in the buprenorphine and morphine groups, respectively (P = 0.36). Similar rates of adverse events were seen in the groups.”
Source: EMPR.com – May 5, 2017
“U.S. health officials said new cases of hepatitis C rose nearly 300 percent from 2010 to 2015, despite the availability of cures for the liver disease, fueled by a spike in the use of heroin and other injection drugs, according to a report released on Thursday.
In 2015, the national reported rate of hepatitis C was 0.8 per 100,000 persons with nearly 34,000 new infections, according to the report by the Centers for Disease Control and Prevention.
Access to clean syringes and a limit on Medicaid barriers to curative treatments for hepatitis C can reduce rates of death from the disease and transmission of the virus to others, the CDC said.”
Source: AOL.com – May 11, 2017
“Chalk up another potential consequence of the U.S. opioid epidemic: The prevalence of hepatitis C infections among pregnant women nearly doubled between 2009 and 2014, U.S. health officials report.
Hepatitis C — which is caused most often by injection drug use — rose 89 percent nationwide among pregnant women. Increases were most notable in West Virginia and rural counties in Tennessee, areas hard-hit by the heroin and prescription painkiller epidemic, the U.S. Centers for Disease Control and Prevention reported.
Nationwide, 35 infants a day were exposed to the contagious liver disease, on average, study authors said.”
Source: USNews.com – May 11, 2017
“The prescription opioid epidemic is shrinking the time it used to take drug users to progress to drug injection, a new Keck School of Medicine of USC-led study suggests.
“The prescription opioid epidemic is creating a heroin epidemic, which will create an injection drug use epidemic,” Bluthenthal said. “We’ve seen the first two. Now we’re waiting to see the last emerge on the national level. I predict we’ll see an uptick in injection-related diseases over the next couple of years.”
The study, published in April in the journal Drug and Alcohol Dependence, is based on 776 drug users in Los Angeles and San Francisco. Participants born in the 1980s or 1990s, on average, took six years to escalate from first illicit drug use to first drug injection. The average for participants born in the 1970s was nine years.
Source: MedicalExpress.com – May 8, 2017
“It’s no secret that there’s a drug overdose crisis in the United States. Opioid overdose deaths have risen 255% from 1999 to 2015. The US has failed to beat the opioid epidemic with drug courts, 12 step rehabs, and even medications like Vivitrol. However, seven other countries have overcome a huge drug overdose crisis very cheaply using technology which is more than 50 years old. Their secret? They have made methadone, an extremely cheap drug which costs less than a dollar a day for a maintenance dose, readily available to everyone who needs it. Rather than mandating expensive and stigmatizing methadone clinics, they allow any patients who need methadone to take their doses in their doctors’ offices or even at pharmacies… for free.”
Source: TheFix.com – May 17, 2017
Links to National News of Interest
Links to State News of Interest
Categories: News Updates